Authors' response
Ann Allergy Asthma Immunol
.
2024 Mar;132(3):402.
doi: 10.1016/j.anai.2023.12.019.
Authors
Sarina Tanimoto
1
,
Michael Kaliner
2
,
Richard Lockey
3
,
Motohiro Ebisawa
4
Affiliations
1
ARS Pharmaceuticals, San Diego, California. Electronic address: sarinat@ars-pharma.com.
2
Institute for Asthma & Allergy, Wheaton, Maryland.
3
University of South Florida, College of Medicine, Tampa, Florida.
4
Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Kanagawa, Japan.
PMID:
38432785
DOI:
10.1016/j.anai.2023.12.019
No abstract available
Publication types
Letter
Comment